Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain.
COVID-19
coronavirus
epidemiology
fatality
hospital admission
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
23 01 2021
23 01 2021
Historique:
accepted:
03
09
2020
pubmed:
30
10
2020
medline:
2
2
2021
entrez:
29
10
2020
Statut:
ppublish
Résumé
Currently, there is a missing link in the natural history of COVID-19, from first (usually milder) symptoms to hospitalization and/or death. To fill in this gap, we characterized COVID-19 patients at the time at which they were diagnosed in outpatient settings and estimated 30-day hospital admission and fatality rates. This was a population-based cohort study. Data were obtained from Information System for Research in Primary Care (SIDIAP)-a primary-care records database covering >6 million people (>80% of the population of Catalonia), linked to COVID-19 reverse transcriptase polymerase chain reaction (RT-PCR) tests and hospital emergency, inpatient and mortality registers. We included all patients in the database who were ≥15 years old and diagnosed with COVID-19 in outpatient settings between 15 March and 24 April 2020 (10 April for outcome studies). Baseline characteristics included socio-demographics, co-morbidity and previous drug use at the time of diagnosis, and polymerase chain reaction (PCR) testing and results. Study outcomes included 30-day hospitalization for COVID-19 and all-cause fatality. We identified 118 150 and 95 467 COVID-19 patients for characterization and outcome studies, respectively. Most were women (58.7%) and young-to-middle-aged (e.g. 21.1% were 45-54 years old). Of the 44 575 who were tested with PCR, 32 723 (73.4%) tested positive. In the month after diagnosis, 14.8% (14.6-15.0) were hospitalized, with a greater proportion of men and older people, peaking at age 75-84 years. Thirty-day fatality was 3.5% (95% confidence interval: 3.4% to 3.6%), higher in men, increasing with age and highest in those residing in nursing homes [24.5% (23.4% to 25.6%)]. COVID-19 infections were widespread in the community, including all age-sex strata. However, severe forms of the disease clustered in older men and nursing-home residents. Although initially managed in outpatient settings, 15% of cases required hospitalization and 4% died within a month of first symptoms. These data are instrumental for designing deconfinement strategies and will inform healthcare planning and hospital-bed allocation in current and future COVID-19 outbreaks.
Sections du résumé
BACKGROUND
Currently, there is a missing link in the natural history of COVID-19, from first (usually milder) symptoms to hospitalization and/or death. To fill in this gap, we characterized COVID-19 patients at the time at which they were diagnosed in outpatient settings and estimated 30-day hospital admission and fatality rates.
METHODS
This was a population-based cohort study.
Data were obtained from Information System for Research in Primary Care (SIDIAP)-a primary-care records database covering >6 million people (>80% of the population of Catalonia), linked to COVID-19 reverse transcriptase polymerase chain reaction (RT-PCR) tests and hospital emergency, inpatient and mortality registers. We included all patients in the database who were ≥15 years old and diagnosed with COVID-19 in outpatient settings between 15 March and 24 April 2020 (10 April for outcome studies). Baseline characteristics included socio-demographics, co-morbidity and previous drug use at the time of diagnosis, and polymerase chain reaction (PCR) testing and results.
Study outcomes included 30-day hospitalization for COVID-19 and all-cause fatality.
RESULTS
We identified 118 150 and 95 467 COVID-19 patients for characterization and outcome studies, respectively. Most were women (58.7%) and young-to-middle-aged (e.g. 21.1% were 45-54 years old). Of the 44 575 who were tested with PCR, 32 723 (73.4%) tested positive. In the month after diagnosis, 14.8% (14.6-15.0) were hospitalized, with a greater proportion of men and older people, peaking at age 75-84 years. Thirty-day fatality was 3.5% (95% confidence interval: 3.4% to 3.6%), higher in men, increasing with age and highest in those residing in nursing homes [24.5% (23.4% to 25.6%)].
CONCLUSION
COVID-19 infections were widespread in the community, including all age-sex strata. However, severe forms of the disease clustered in older men and nursing-home residents. Although initially managed in outpatient settings, 15% of cases required hospitalization and 4% died within a month of first symptoms. These data are instrumental for designing deconfinement strategies and will inform healthcare planning and hospital-bed allocation in current and future COVID-19 outbreaks.
Identifiants
pubmed: 33118037
pii: 5942697
doi: 10.1093/ije/dyaa190
pmc: PMC7665572
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1930-1939Subventions
Organisme : Bill & Melinda Gates Foundation
ID : INV-016201
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the International Epidemiological Association.
Références
BMC Geriatr. 2019 Aug 5;19(1):210
pubmed: 31382895
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Clin Epidemiol. 2019 Jul 05;11:509-518
pubmed: 31456649
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
PLoS One. 2014 Oct 20;9(10):e109706
pubmed: 25329578
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Clin Epidemiol. 2019 Dec 03;11:1015-1024
pubmed: 31819655
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Vaccine. 2011 Jul 12;29(31):5047-52
pubmed: 21620915
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Nat Commun. 2020 Oct 6;11(1):5009
pubmed: 33024121
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Emerg Infect Dis. 2018 Oct;24(10):1964-1966
pubmed: 30226169
Vaccine. 2010 Dec 16;29(2):240-6
pubmed: 21044667
Fam Pract. 1994 Sep;11(3):307-17
pubmed: 7843523
Nature. 2020 Apr 29;:
pubmed: 32350436
Inform Prim Care. 2011;19(3):135-45
pubmed: 22688222
BMJ. 2018 Sep 5;362:k3359
pubmed: 30185425
Science. 2020 Mar 20;367(6484):1287-1288
pubmed: 32193299
Clin Infect Dis. 2020 Nov 5;71(8):e202-e205
pubmed: 31995171